IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.066
EU - Europa 2.411
AS - Asia 415
SA - Sud America 10
OC - Oceania 6
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.912
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.060
GB - Regno Unito 675
IE - Irlanda 561
CN - Cina 307
IT - Italia 264
SE - Svezia 255
UA - Ucraina 213
FR - Francia 117
DE - Germania 110
FI - Finlandia 63
ES - Italia 41
BE - Belgio 34
VN - Vietnam 30
SG - Singapore 26
IN - India 25
RU - Federazione Russa 23
LU - Lussemburgo 18
CL - Cile 9
IR - Iran 9
CA - Canada 6
CZ - Repubblica Ceca 6
TR - Turchia 6
AU - Australia 5
NL - Olanda 4
RO - Romania 4
BD - Bangladesh 3
BG - Bulgaria 3
PL - Polonia 3
AL - Albania 2
CH - Svizzera 2
DK - Danimarca 2
HK - Hong Kong 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
MW - Malawi 2
NO - Norvegia 2
PT - Portogallo 2
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.912
Salva come PNG Salva come JPEG
Città #
Southend 630
Dublin 556
Fairfield 538
Ashburn 269
Woodbridge 251
Chandler 230
Ann Arbor 211
Wilmington 198
Cambridge 188
Seattle 184
Jacksonville 179
Houston 168
Princeton 91
Siena 74
New York 65
Beijing 59
Nanjing 56
Shanghai 45
San Mateo 39
Málaga 37
Brussels 34
Helsinki 32
Boardman 30
Dong Ket 29
San Diego 26
Shenyang 22
Moscow 19
Los Angeles 18
Nanchang 18
Jiaxing 15
Singapore 15
Roodt-sur-Syre 14
Rome 12
Milan 11
Hebei 10
Munich 10
Venezia 10
London 9
Zhengzhou 9
Arezzo 8
Florence 8
Kunming 8
San Francisco 8
Santiago 8
Tianjin 7
Aosta 6
Dearborn 6
Fremont 6
Norwalk 6
Redwood City 6
Zanjan 6
Brno 5
Changsha 5
Düsseldorf 5
Ningbo 5
Taizhou 5
Tappahannock 5
Viareggio 5
Vijayawada 5
Washington 5
Guangzhou 4
Hangzhou 4
Leawood 4
Nuremberg 4
Bangalore 3
Jinan 3
Lastra a Signa 3
Livorno 3
Narni 3
New Bedfont 3
Sacramento 3
Santa Maria Capua Vetere 3
Winnipeg 3
Alessandria 2
Amsterdam 2
Andover 2
Bathinda 2
Bologna 2
Canberra 2
Dresden 2
Glasgow 2
Groningen 2
Gunzenhausen 2
Haikou 2
Hefei 2
Hong Kong 2
Hyderabad 2
Islington 2
Izmir 2
Kiskunfelegyhaza 2
Lanzhou 2
Lilongwe 2
Loughborough 2
Luxembourg 2
Madrid 2
Marseille 2
Mestre 2
Montemurlo 2
Montespertoli 2
Monza 2
Totale 4.636
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 213
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 192
C-Met targeting in advanced gastric cancer: An open challenge 188
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 174
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 170
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 165
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 164
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 147
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 145
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 143
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 143
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 138
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 135
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 135
Gastric cancer: Current status of lymph node dissection 133
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 131
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 129
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 126
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 116
Short-term and long-term risk factors in gastric cancer 116
null 112
null 112
null 110
null 109
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 105
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 104
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 103
null 103
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 98
null 98
null 98
null 96
null 96
Treatment of bone metastases with dichloromethylene bisphosphonate 95
null 89
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 88
null 88
null 87
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 87
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 83
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 81
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 79
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 78
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 65
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 59
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 52
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 52
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 50
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 47
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 45
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 42
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 42
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 42
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 42
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 42
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 41
null 39
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 38
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 36
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 34
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 31
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 27
Surgical management of advanced gastric cancer: An evolving issue 25
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 17
Totale 6.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.375 128 48 85 176 65 83 113 205 199 121 51 101
2020/20211.143 48 114 48 108 69 114 69 178 91 134 87 83
2021/2022727 57 63 51 45 31 39 32 33 35 72 97 172
2022/2023972 57 70 141 108 86 205 32 79 98 47 26 23
2023/2024925 33 16 91 46 27 239 311 9 0 46 48 59
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 6.070